![]() |
Volumn 22, Issue 5, 2002, Pages 417-430
|
Health economic evaluations: The special case of end-stage renal disease treatment
a,b
|
Author keywords
Cost effectiveness analysis; Dialysis; Kidney transplantation; Meta analysis
|
Indexed keywords
ARTICLE;
CONTROLLED STUDY;
COST EFFECTIVENESS ANALYSIS;
HEALTH ECONOMICS;
HEMODIALYSIS;
HUMAN;
KIDNEY DISEASE;
KIDNEY FAILURE;
KIDNEY TRANSPLANTATION;
MEDICAL ASSESSMENT;
MEDICAL LITERATURE;
MEDICAL PRACTICE;
METHODOLOGY;
UNITED STATES;
ATTITUDE TO HEALTH;
COST-BENEFIT ANALYSIS;
DIRECT SERVICE COSTS;
EVIDENCE-BASED MEDICINE;
HEALTH CARE COSTS;
HEMODIALYSIS UNITS, HOSPITAL;
HEMODIALYSIS, HOME;
HUMANS;
KIDNEY FAILURE, CHRONIC;
KIDNEY TRANSPLANTATION;
PERITONEAL DIALYSIS;
PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY;
QUALITY-ADJUSTED LIFE YEARS;
RENAL DIALYSIS;
SOCIAL VALUES;
TECHNOLOGY ASSESSMENT, BIOMEDICAL;
TIME FACTORS;
TREATMENT OUTCOME;
VALUE OF LIFE;
|
EID: 0036738342
PISSN: 0272989X
EISSN: None
Source Type: Journal
DOI: 10.1177/027298902320556118 Document Type: Article |
Times cited : (299)
|
References (35)
|